Exact Mass: 569.1321898

Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1].

C25H33Cl2N5O6_17,18-Dichloro-3,13-diethyl-6-(hydroxymethyl)-9-phenyldodecahydropyrrolo[1,2-d][1,4,7,10,13]pentaazacyclohexadecine-1,4,7,11,14(8H)-pentone

NCGC00384857-01_C25H33Cl2N5O6_17,18-Dichloro-3,13-diethyl-6-(hydroxymethyl)-9-phenyldodecahydropyrrolo[1,2-d][1,4,7,10,13]pentaazacyclohexadecine-1,4,7,11,14(8H)-pentone

Cys Met Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

Cys Met Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

Cys Trp Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

Met Cys Met Trp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

Met Cys Trp Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

Met Met Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

Met Met Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

Met Trp Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

Met Trp Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

Trp Cys Met Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

Trp Met Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

Trp Met Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C22H29N5O9P2 (569.1440444000001)

Emricasan

C26H27F4N3O7 (569.178504)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

ferric benzoylacetonate

C31H29FeO7 (569.1262574)

Motesanib diphosphate

Motesanib Diphosphate (AMG-706)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

LEUCO PATENT BLUE VIOLET

C27H34N2NaO6S2 (569.1755884)

Montelukast Methyl Ketone

C34H32ClNO3S (569.1791312)

3(2H)-Benzoxazolepropanesulfonic acid, 2-[4-(1,3-dibutyltetrahydro-4,6-dioxo-2-thioxo-5(2H)-pyrimidinylidene)-2-butenylidene]-, sodium salt

3(2H)-Benzoxazolepropanesulfonicacid,2-[4-(1,3-dibutyltetrahydro-4,6-dioxo-2-thioxo-5(2H)-pyrimidinylidene)-2-buten-1-ylidene]-,sodium salt (1:1)

C26H32N3NaO6S2 (569.1630132)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D003879 - Dermatologic Agents

Enasidenib Mesylate

C20H21F6N7O4S (569.1279858)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C137826 - Isocitrate Dehydrogenase Inhibitor > C168619 - IDH2 inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes.

Unii-Q77S2qtc0T

C26H25Cl2N7O4 (569.134499)

P1-MurNAc-L-Ala-D-Glu

C19H28N3O15P-4 (569.1257988)

7,8-Dihydrofolate diglutamate

C24H25N8O9-3 (569.174442)

Lactonamycin

C28H27NO12 (569.1533182000001)

An organic heterohexacyclic compound isolated from the culture broth of Streptomyces rishiriensis. It is an antibiotic with antibacterial activity.

{3-[(6-(anilinocarbonyl)-5-(4-ethoxyphenyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2(3H)-ylidene)methyl]phenoxy}acetic acid

C31H27N3O6S (569.1620482000001)

(4-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone

C28H28FN3O5S2 (569.145433)

(4-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone

C28H28FN3O5S2 (569.145433)

(3-5)-Adenylyluridine

6-O-phospho-muramyl dipeptide

C19H30N4O14P-3 (569.149607)

(3-5)-Uridylyladenosine

HR1917

C26H23N7O4. 2HCl (569.134499)

ApU

UpA

C28H27NO12 (569.1533182000001)

(2r)-1',5,8,9,9',10-hexahydroxy-7-methoxy-3'-[(1e,3e)-penta-1,3-dien-1-yl]-6',7'-dihydrospiro[anthracene-2,8'-cyclopenta[g]isoquinoline]-1,3,4-trione

C31H23NO10 (569.1321898)

2,9-dihydroxy-15-[(5-hydroxy-6-methyloxan-2-yl)oxy]-18-methoxy-6-methyl-17,21-dioxa-6-azahexacyclo[11.10.0.0³,¹¹.0⁴,⁸.0¹⁵,²².0¹⁸,²²]tricosa-1,3,8,10,12-pentaene-7,14,20,23-tetrone

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

1',5,8,9,9',10-hexahydroxy-7-methoxy-3'-(penta-1,3-dien-1-yl)-6',7'-dihydrospiro[anthracene-2,8'-cyclopenta[g]isoquinoline]-1,3,4-trione

C31H23NO10 (569.1321898)

(3r,6r,13r,17s,18r,18as)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

8-chloro-3,5,22,28-tetrahydroxy-21,24-dimethoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one

8-chloro-3,5,22,28-tetrahydroxy-21,24-dimethoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one

C28H24ClNO10 (569.1088674)

(13s,21r,22s,24r)-8-chloro-3,5,22,28-tetrahydroxy-21,24-dimethoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one

(13s,21r,22s,24r)-8-chloro-3,5,22,28-tetrahydroxy-21,24-dimethoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one

C28H24ClNO10 (569.1088674)

17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one